It will present updated approaches to acute stroke intervention, rehabilitation, and secondary prevention. Discussions will highlight the role of neuroimaging, thrombolytic therapy, and multidisciplinary recovery programs.

Gain insights into the latest methods for diagnosing, monitoring, and treating epilepsy. Topics include pharmacologic advancements, surgical interventions, and neuromodulation techniques for drug-resistant cases.

Focus on the diagnosis and treatment of neurological diseases with immune components, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. Emphasis will be placed on immunotherapies and emerging research.

Review current strategies in managing Parkinson’s disease and related movement disorders. Topics will include deep brain stimulation, medication optimization, and neurorehabilitation advancements.

Explore the evolving science behind chronic headaches and migraines. Learn how to tailor treatments using preventive therapies, lifestyle adjustments, and novel pharmacological agents like CGRP inhibitors.

It  will focus on conditions like ALS, myasthenia gravis, and peripheral neuropathies. Experts will share case-based insights into diagnostic workups and recent advances in gene-based and antibody-directed therapies.

Address the rising burden of dementia-related conditions, including Alzheimer’s disease. The session will cover cognitive assessment tools, supportive therapies, and patient centered care approaches for preserving quality of life.

Explore ethical challenges in neurology, such as end-of-life care, informed consent in cognitive impairment, and treatment boundaries. Learn frameworks to support compassionate and patient-focused decision making.